Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 12,640
-210 (-1.63%)
At close: Jun 5, 2025, 3:30 PM KST
KRX:271980 Revenue
Jeil Pharmaceutical Co.,Ltd had revenue of 163.02B KRW in the quarter ending March 31, 2025, a decrease of -4.34%. This brings the company's revenue in the last twelve months to 697.15B, down -1.22% year-over-year. In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B, down -3.01%.
Revenue (ttm)
697.15B
Revenue Growth
-1.22%
P/S Ratio
0.26
Revenue / Employee
739.29M
Employees
943
Market Cap
184.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| LigaChem Biosciences | 146.42B |